×
About 53,235 results

ALLMedicine™ Anemia Center

Research & Reviews  16,770 results

Clinical observation of low-dose combination chemotherapy in refractory/recurrent parox...
https://doi.org/10.1002/jcla.24239
Journal of Clinical Laboratory Analysis; Li L, Liu H et. al.

Jan 15th, 2022 - We performed a retrospective analysis to investigate the clinical characteristics and therapeutic strategies of 20 refractory/recurrent PNH patients, including the clinical efficacy of chemotherapy treatment, safety, and survival. The clinical dat...

Associations between Autoimmune Conditions and Gastric Cancer Risk among Elderly Adults...
https://doi.org/10.14309/ajg.0000000000001622
The American Journal of Gastroenterology; Song M, Camargo MC et. al.

Jan 15th, 2022 - Pernicious anemia (PA) is a risk factor for gastric cancer. Other autoimmune conditions may also contribute. In a case-control study, we evaluated 47 autoimmune conditions among 35,499 gastric cancers and 200,000 cancer-free controls. Six conditio...

Evaluating test utilization for anemia during pregnancy.
https://doi.org/10.1111/ijlh.13797
International Journal of Laboratory Hematology; Santana G, Reise R et. al.

Jan 15th, 2022 - To evaluate, using longitudinal laboratory data, potential care gaps, and the prevalence of anemia in pregnant women residing in New Mexico, USA. A total of 985 pregnant women aged 13-60 were included from December 1, 2018 to December 1, 2019. Par...

Lidocaine in ERAS for FESS
https://clinicaltrials.gov/ct2/show/NCT03047070

Jan 14th, 2022 - Functional endoscopic sinus surgery (FESS) is a commonly performed procedure in the head and neck field. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes. Use of vasoactive drugs t...

Dietary Intake, Health and Micronutrient Status in Haiti
https://clinicaltrials.gov/ct2/show/NCT04034381

Jan 14th, 2022 - Women of reproductive age and young children are especially vulnerable to micronutrient deficiencies which may lead to life-long disabilities. In Haiti, deficiencies in micronutrients such as iron, zinc, and vitamin A, are likely prevalent, but re...

see more →

Guidelines  25 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH...
https://doi.org/10.1200/JCO.18.02142
Journal of Clinical Oncology : Official Journal of the Am... Bohlius J, Bohlke K et. al.

Apr 11th, 2019 - To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. PubMed and the Cochrane Library were searched for randomiz...

see more →

Drugs  730 results see all →

Clinicaltrials.gov  943 results

Dietary Intake, Health and Micronutrient Status in Haiti
https://clinicaltrials.gov/ct2/show/NCT04034381

Jan 14th, 2022 - Women of reproductive age and young children are especially vulnerable to micronutrient deficiencies which may lead to life-long disabilities. In Haiti, deficiencies in micronutrients such as iron, zinc, and vitamin A, are likely prevalent, but re...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Jan 14th, 2022 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

Lidocaine in ERAS for FESS
https://clinicaltrials.gov/ct2/show/NCT03047070

Jan 14th, 2022 - Functional endoscopic sinus surgery (FESS) is a commonly performed procedure in the head and neck field. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes. Use of vasoactive drugs t...

Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
https://clinicaltrials.gov/ct2/show/NCT05190263

Jan 13th, 2022 - Health care structure analysis and recruitment (phase 1): In a first step, data on care facilities treating patients in the above indica-tions in Germany will be collected (gastroenterology, gynecology, hema-tology/oncology, and pneumology hospita...

A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia
https://clinicaltrials.gov/ct2/show/NCT04899661

Jan 12th, 2022 - In this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and women who have renal anemia, a condition in which the kidneys do not make enough of a hormone that helps the body make new red b...

see more →

News  2,728 results

Fast Five Quiz: Relapsed/Refractory Multiple Myeloma
https://www.medscape.com/viewarticle/962961

Jan 11th, 2022 - Multiple myeloma is a plasma cell cancer characterized by proliferation of monoclonal plasma cells in bone marrow, leading to an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell...

CLN-081 Continues to Elicit Encouraging, Durable Responses in EGFR Exon 20 Insertion+ NSCLC
https://www.onclive.com/view/cln-081-continues-to-elicit-encouraging-durable-responses-in-egfr-exon-20-insertion-nsclc

Jan 6th, 2022 - CLN-081 (TAS6417) continued to produce encouraging, durable responses with favorable safety and tolerability in patients with non–small cell lung cancer (NSCLC) whose tumors harbor EGFR exon 20 insertion mutations and who have progressed on or aft...

My favorite physical exam pearls
https://www.mdedge.com/internalmedicine/article/250500/mixed-topics/my-favorite-physical-exam-pearls
Douglas S. Paauw, MD

Jan 6th, 2022 - I would like to start the new year off by returning to the past – when the physical exam was emphasized and utilized in decision making. I think a big reason that its use has diminished in recent years is due to the physical exam not having been e.

Complete Response Rate Doubles When Aplastic Anemia Patients Receive Eltrombopag
https://www.medscape.com/viewarticle/966117

Jan 6th, 2022 - (Reuters Health) - Adding the Novartis drug eltrombopag to standard immunosuppressive therapy with horse antithymocyte globulin (ATG) more than doubles the three-month complete response rate for people receiving first-time treatment for severe apl...

Finally, a 'New Standard' for Severe Aplastic Anemia
https://www.medpagetoday.com/hematologyoncology/anemia/96519

Jan 5th, 2022 - For first-line treatment of severe aplastic anemia, adding eltrombopag (Promacta) to standard immunosuppressive therapy improved the rate, speed, and depth of hematologic response in the phase III RACE trial. The oral thrombopoietin-receptor agoni...

see more →

Patient Education  98 results see all →